Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Overview

About this study

The purpose of this study is to evaluate the effectiveness of a cognitive behavioral multicomponent treatment program in improving pain, mood, and functioning while reducing medication non-adherence in breast cancer patients with Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Female patient ≥ 18 years old.
A breast cancer survivor ECOG ≤ 2, stage 0-III HR+ who is experiencing musculoskeletal symptoms associated with aromatase inhibitors intake.
Patients must be at least 6 months on aromatase inhibitors and for no more than 7 years.

Exclusion Criteria:

Breast cancer survivor patients that are not in aromatase inhibitor’s treatment or have less than 6 months of treatment or more than 7 years of treatment.
Asymptomatic patients.
Patient is less than 18 years old.
Patient that are not a patient of Mayo Clinic.
Patients with stage IV breast carcinoma.
Patients that are HR –.
Patients that are ECOG 3 or more.

Eligibility last updated 3/31/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Barbara Bruce, Ph.D., L.P.	Open for enrollment	Contact information: Alejandra Cuartas-Abril M.S. (904) 956-8885 Cuartas-Abril.Alejandra@mayo.edu

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Barbara Bruce, Ph.D., L.P.

Open for enrollment

Contact information:

Alejandra Cuartas-Abril M.S.

(904) 956-8885

Cuartas-Abril.Alejandra@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials